Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899626 · ClinicalTrials.gov registry record
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
A clinical trial of Colorectal Cancer and Pancreatic Cancer, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 2
- Study locations
NCT00899626 is a study of Colorectal Cancer and Pancreatic Cancer that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 5,000 participants, above the 1,498-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (234% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00899626, a study of Colorectal Cancer and Pancreatic Cancer, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.
Conditions Studied
Study Locations (2)
Tennessee
- Veterans Affairs Medical Center - Nashville - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2002-06 |
| Est. Completion | 2045-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899626
The ClinicalTrials.gov registry entry for NCT00899626 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,498-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (234% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00899626 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00899626 about?
NCT00899626 is a clinical study titled "Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients". RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at g...
What is the current status of trial NCT00899626?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2002-06. Estimated completion is 2045-10.
What conditions does trial NCT00899626 study?
This clinical trial studies the following conditions: Colorectal Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Precancerous Condition.
Who is sponsoring clinical trial NCT00899626?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00899626 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.